In lung, prostate, and hepatocellular cancer, researchers found that UBTD1 is found to catalyze Yes1-associated transcriptional regulator (YAP) protein degradation and inhibit the development of lung, prostate, and hepatocellular cancer [7, 8]. This evidence concerns the gene UBTD1 and hepatocellular carcinoma.